Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Down 35.4% in August

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the target of a significant decrease in short interest in August. As of August 14th, there was short interest totaling 11,255 shares, a decrease of 35.4% from the July 30th total of 17,416 shares. Currently, 1.2% of the shares of the stock are short sold. Based on an average daily volume of 30,001 shares, the short-interest ratio is presently 0.4 days.

Cuprina Holdings (Cayman) Price Performance

NASDAQ CUPR traded up $0.05 during trading hours on Wednesday, reaching $2.95. The company had a trading volume of 2,888 shares, compared to its average volume of 1,261,531. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07. The stock has a 50-day moving average of $3.84 and a 200 day moving average of $3.23. Cuprina Holdings has a 1-year low of $1.76 and a 1-year high of $19.60.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.